Who should get what slice of the pie once the medicine is available in public clinics? And are numbers alone what would drive decisions?
None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year
The need for medical oxygen to treat Covid-19 patients in low- and middle-income countries has more than doubled in the past two months, and many of these countries faced oxygen shortages before the pandemic